CROI 2024 Program Guide

Poster Sessions

Remdesivir+Dexamethasone vs Dexamethasone for the Treatment of COVID-19: Real-World Study in the US Essy Mozaffari , Aastha Chandak, Robert L Gottlieb, Chidinma Chima Melton, Mark Berry, Thomas Oppelt, Jason F Okulicz, Alpesh N Amin, Andre C Kalil, Tobias Welte, Paul E Sax Real-Life Experience on the Use of Remdesivir: A Propensity Score Matched Analysis Francesco Di Gennaro , Luisa Frallonardo, Giacomo Guido, Francesco Vladimiro Segala, Nicola Veronese, Annalisa Saracino Molnupiravir vs Favipiravir: An RCT in Outpatients At-Risk for COVID-19 in Thailand Nicolas Salvadori, Gonzague Jourdain, Rungroj Krittayaphong, Taweegrit Siripongboonsitti, Subsai Kongsaengdao, Parichart Sakulkonkij, Nasikarn Angkasekwinai, Sarunyou Chusri, Tanavit Mekavuthikul, Anucha Apisarnthanarak, Sirawat Srichatrapimuk, Suraphan Sangsawang, Piya Hanvoravongchai, Pra-ornsuda Sukrakanchana, Prasert Auewarakul AGILE CST-8 Phase I Trial of Combined Nirmatrelvir/r and Molnupiravir for Mild-Moderate COVID-19 Saye Khoo , Richard J Fitzgerald, Shazaad Ahmad, Chris Edwards, Geoff Saunders, Emma Knox, Calley Middleton, William Greenhalf, Laura Else, Victoria Shaw, Thomas Fletcher, Helen Reynolds, Gareth Griffiths, for the AGILE CST-8 Study Team Viral and Symptom Rebound After COVID-19 Monoclonal Antibody Therapy in the ACTIV-2 Trial Kara W. Chew , Brooke McGinley, Carlee Moser, Jonathan Z Li, Teresa H Evering, Justin Ritz, David Margolis, David Wohl, Michael D Hughes, Eric Daar, Judith S Currier, Joseph J Eron, Davey M Smith, for the ACTIV-2/A5401 Study Team Risk of SARS-CoV-2 Infection in Patients With Hematologic Diseases Receiving Tixagevimab/Cilgavimab Alessandra Vergori, Alessandro Cozzi-Lepri, Marta Chiuchiarelli, Valentina Mazzotta, Elisabetta Metafuni, Giulia Matusali, Valentina Siciliano, Jessica Paulicelli, Eleonora Alma, Agostina Siniscalchi, Elisabetta Abruzzese, Simona Sica, Massimo Fantoni, Andrea Antinori, Antonella Cingolani Immunogenicity of Tixagevimab/Cilgavimab for COVID-19 in Immunocompromised Children and Adolescents Jassada Buaboonnam, Supattra Rungmaitree , Nuntawan Piyaphanee, Sirirat Charuvanij, Onsiri Pitisuttithum, Katherine Copeland, Chatkamol Pheerapanyawaranun, Suvimol Niyomnaitham, Kulkanya Chokephaibulkit Sotrovimab Lacks Efficacy in Treatment of Syrian Golden Hamsters Infected With SARS-CoV-2 BQ.1.1 Lee Tatham , Joanne Sharp, Megan Neary, Joanne Herriott, Edyta Kijak, Eduardo Gallardo-Toledo, Helen Cox, Chloe Bramwell, Anthony Valentijn, Usman Arshad, Henry Pertinez, Paul Curley, Rajith Rajoli, James P Stewart, Andrew Owen First-in-Human Phase I Trial of an Adjuvanted SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Natalie Collins , Brittany Ober Shepherd, Paul T Scott, Melanie McCauley, Jack Hutter, Christine Lee, Ivelese Guzman, Adrian McDermott, Shelia Peel, M Gordon Joyce, Merlin L Robb, Nelson L Michael, Sandhya Vasan, Kayvon Modjarrad, for the SpFN/ALFQ Study Group

665 LB

666

667

Poster Sessions • Tuesday

668 LB

669

670

671

672

673

CROI 2024 119

New Investigator Scholarship

LB

NIS

Late-Breaking